发明名称 |
METHOD AND KIT FOR PROGNOSIS OF OPA1 GENE INDUCED DISEASES, E.G. KJERS OPTIC ATROPHY. |
摘要 |
<p>The present invention provides the use of the activity or expression level of Nuclear factor (erythroid -derived 2)-like 2 (NRF2)-activated genes products, e.g. SOD1 and CAT, in the prognosis of an OPA1 gene- or OPA1 gene product- deficit-induced disease, e.g. optic atrophy and optic neuropathy, or related complications by detecting expression or activity in a biological sample selected from fibroblasts, epithelial cells, blood samples or a mixture thereof, of a patient affected or suspected to be affected by said disease.</p> |
申请公布号 |
WO2015144924(A1) |
申请公布日期 |
2015.10.01 |
申请号 |
WO2015EP56814 |
申请日期 |
2015.03.27 |
申请人 |
UNIVERSITE TOULOUSE III-PAUL SABATIER;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE |
发明人 |
DAVEZAC, NOÉLIE;BELENGUER, PASCALE;MILLET, AURÉLIE |
分类号 |
C12Q1/68;G01N33/573;G01N33/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|